logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Huakang Biomedical (08622.HK): 6 million purchase rights have been exercised.

date
05/12/2025
This is a news update from the Intelligent Finance app. Huakang Biomedical (08622.HK) has announced that on December 5, 2025, 6 million share options granted under the 2020 stock option plan have been exercised in accordance with the rules of the 2020 stock option plan.
Latest
1 m ago
German industrial new orders in October increased by 1.5% compared to the previous month.
2 m ago
"The scheduled hearing for the Sci-Tech Innovation Board IPO review is set to take place on December 12th."
2 m ago
Vanke A: The company has decided to waive the issuer's redemption option for "21 Vanke 02".
4 m ago
Roman Holdings (605289.SH), a holding subsidiary, signed a contract for the sale and service of 4.48 billion yuan worth of computing power equipment.
5 m ago
After Netflix announced its acquisition of Warner Bros. Discovery's production studios and streaming business division for $72 billion, its pre-market stock price fell by 3.1%.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.